Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

eVTE (Electronic Venous Thromboembolism): A Cluster, Randomized, Step-wedge Type II Hybrid Study of an Alert Recommending Extended Duration Thromboprophylaxis for At-risk Discharging Medical Patients to Prevent VTE.

NCT06232551 is registered in ClinicalTrials.gov with Scott C. Woller, MD as lead sponsor.

NCT NCT06232551
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06232551 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
eVTE (Electronic Venous Thromboembolism): A Cluster, Randomized, Step-wedge Type II Hybrid Study of an Alert Recommending Extended Duration Thromboprophylaxis for At-risk Discharging Medical Patients to Prevent VTE.
Lead sponsor
Scott C. Woller, MD
Phase
Not applicable
Overall status
Unknown status
Start date
June 1, 2024
Completion date
September 30, 2025
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

deep vein thrombosis, hospitalism, pulmonary embolism and thrombosis, venous thromboembolic disease